MARKET

CASI

CASI

CASI Pharms
NASDAQ

Real-time Quotes | Nasdaq Last Sale

3.350
+0.100
+3.08%
Closed 17:59 09/20 EDT
OPEN
3.240
PREV CLOSE
3.250
HIGH
3.350
LOW
3.150
VOLUME
916.12K
TURNOVER
--
52 WEEK HIGH
5.92
52 WEEK LOW
2.730
MARKET CAP
266.80M
P/E (TTM)
-7.5450
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of CASI and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 1 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

CASI News

  • Week In Review: Investor Group Bids $4.6 Billion To Acquire China Biologic
  • Seeking Alpha - Article.17h ago
  • New president at CASI Pharma
  • seekingalpha.3d ago
  • CASI Pharmaceuticals Announces The Promotion Of Larry Zhang To President
  • PR Newswire.3d ago
  • China NMPA Accepts Clinical Trial Application For CASI's CD19 CAR-T-Product
  • PR Newswire.09/16 11:00

More

Industry

Biotechnology & Medical Research
+0.62%
Pharmaceuticals & Medical Research
+0.95%

Hot Stocks

Name
Price
%Change

About CASI

CASI Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on the acquisition, development and commercialization of therapeutics for cancer and other medical needs. It operates through the development of targeted therapeutics for the treatment of cancer segment. Its product pipeline includes internal development of its lead drug candidate, ENMD-2076; MARQIBO, ZEVALIN and EVOMELA, and early-stage candidates in preclinical development. Its ENMD-2076 is an orally active, Aurora A/angiogenic kinase inhibitor with a kinase selectivity profile and multiple mechanisms of action. Its Marqibo is a sphingomyelin/cholesterol liposome-encapsulated, formulation of vincristine sulfate. Its ZEVALIN (ibritumomab tiuxetan) injection for intravenous use is a CD20-directed radiotherapeutic antibody. Its EVOMELA is an intravenous formulation of melphalan being investigated by Spectrum in the multiple myeloma transplant setting. Its pipeline also includes 2ME2 (2-methoxyestradial).
More

Webull offers CASI Pharmaceuticals Inc (CASI) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.